Health Care Counsel Blog

816 total results. Page 8 of 33.

Darrell S. Gay, Nicholas L. Collins
On May 5, 2021, in response to the COVID-19 pandemic, Governor Andrew Cuomo signed the New York Health and Essential Rights Act (“NY HERO Act”) into law. The NY HERO Act requires extensive workplace health and safety protections and seeks to protect employees from exposure and disease from future ai
With COVID-19 rates again rising rapidly among unvaccinated individuals, California health care and government leaders are pushing to increase vaccination rates for healthcare workers in the state.
Douglas A. Grimm
Expanded telehealth services temporarily permitted during the COVID-19 public health emergency would be further extended to December 21, 2023, in order for CMS to conduct analyses regarding permanent expansion of certain telehealth services.
On July 19, 2021, the Secretary of Health and Human Services (HHS) renewed the declaration of the COVID-19 Public Health Emergency (PHE), effective July 20, 2021.
Stephanie Trunk
The Centers for Medicare & Medicaid Services (CMS) calendar year 2022 rule proposing changes to payment policies under the Physician Fee Schedule (PFS) and Medicare Part B (the Proposed Rule) will officially be published in the Federal Register on July 23, 2021.
Caroline Turner English, Alison Lima Andersen
On July 1, 2021, the Departments of Health and Human Services, Labor, and Treasury, and the Office of Personnel Management, released a much-anticipated interim final rule designed to protect Americans from surprise medical bills.
D. Jacques Smith, Randall A. Brater, Elizabeth Satarov
A regional hospital system in Akron, Ohio, Akron General Health System (AGHS) reached a $21.25 million settlement over allegations that an improper physician referral arrangement violated the Anti-Kickback Statute, Physician Self-Referral Law, and the False Claims Act (FCA).
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
In this clip from our webinar, “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines,” Health Care Partner Jill Steinberg addresses the operational and regulatory concerns of mandating the COVID-19 vaccine.
Stephanie Trunk
The United States Supreme Court has agreed to hear a case that has a direct impact on the 340B Drug Discount Program (the 340B Program) and how Medicare will reimburse hospitals for dispensing of 340B covered drugs, as well as other reimbursement issues.
D. Jacques Smith, Randall A. Brater, Mattie Bowden
On June 23, 2021, CVS Pharmacy Inc. was cleared of claims of overcharging drug purchasers by more than $121 million for general drugs. This verdict comes after a week-long trial in the Northern District of California beginning June 7, 2021.
June 24, 2021 12:00 PM - 1:30 PM
Lowell C. Brown, Annie Chang Lee
Health Care Partner Lowell Brown and Associate Annie Chang Lee will present as part of the California Association Medical Staff Services’ (CAMSS) 50th Annual Education Forum on June 24, 2021.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
On June 15, 2021, the Department of Justice (DOJ) filed a False Claims Act (FCA) suit against Paksn Inc., Prema Thekkek and one of its owners, and seven skilled nursing facilities (SNFs) owned by Thekkek and/or operated by Paksn.
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
Our panel offers insight on providing incentives vs. mandating the COVID-19 vaccine during the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar.
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
Our panel kicks off the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar with this timely question.
Douglas A. Grimm
Take note, all providers who received Provider Review Fund (PRF) payments – there are changes in the reporting deadlines and requirements.
Emily M. Leongini
On March 31, 2021, New York Governor Andrew Cuomo signed the Marijuana Regulation and Taxation Act (MRTA) into law, legalizing adult-use cannabis in the state and establishing a regulatory framework to govern what likely will be one of the nation’s largest cannabis markets.
Stephanie Trunk
In July 2020, the Trump Administration issued an Executive Order (the EO) directing the Secretary of the Department of Health and Human Services (HHS) to take certain actions and finalize rulemakings designed to “support the goal of safe importation of prescription drugs.”
Debra Albin-Riley
Los Angeles Partner Debra Albin-Riley recently argued before the California Supreme Court in a closely-watched case involving the scope of anti-SLAPP protection for medical staff peer review.
June 8, 2021 - June 11, 2021
Stephanie Trunk
Health Care Partner Stephanie Trunk is presenting twice at the Informa Medicaid & Government Pricing Congress June 8-11, 2021.
Stephanie Trunk
The Minnesota Department of Health (MDH) will host a public, virtual meeting on Thursday, June 10, 2021, at 1 p.m. Central time to present and request feedback on draft reporting guidelines for the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62.J.84).
June 3, 2021 11:00 AM - 11:50 AM
Anne M. Murphy
Join Arent Fox Partner Anne Murphy as she moderates a panel on Emerging Governance Issues for health care organizations.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold
On May 21, 2021, SavaSeniorCare LLC and several of its affiliates, which own and operate skilled nursing facilities across the country, agreed to pay $11.2 million to resolve claims that the companies billed Medicare for rehabilitation therapy services that were not reasonable or necessary.
May 26, 2021 12:00 PM - 1:00 PM
Debra Albin-Riley, Sarah G. Benator
Health Care Partner Debra Albin-Riley and Counsel Sarah Benator will present a webinar for the California Society for Healthcare Attorneys (CSHA) on May 26, 2021.
Stephanie Trunk
Similar to the laws of several other states, the North Dakota law contains three main disclosure requirements that apply to “drug manufacturers”
Anne M. Murphy
Several recent surveys and reports by governance and trade associations provide a useful overview of the duties, roles, challenges, and internal relationships of the corporate general counsel, as well as governing board needs and priorities.